Company to pay up to $7.8M over contaminated syringes

Federal prosecutors say a drug and medical device manufacturer has agreed to pay up to $7.8 million for selling contaminated syringes.

Authorities announced Wednesday that B. Braun will avoid in exchange for implementing procedures to improve oversight of its suppliers. The company will pay $4.8 million in penalties and forfeited profits, plus up to $3 million in restitution.

The settlement comes in response to the sale of contaminated syringes that prosecutors say led to an outbreak of bacterial infections and at least five deaths. The B. Braun-branded syringes were manufactured by another firm.

B. Braun says it's committed to patient safety and has agreed to undertake compliance measures related to monitoring of third-party manufacturers.

The is based in Melsungen, Germany. Its U.S. headquarters are in Bethlehem, Pennsylvania.

Explore further

Olympus to pay $646 mn for bribing hospitals, doctors

© 2016 The Associated Press. All rights reserved.

Citation: Company to pay up to $7.8M over contaminated syringes (2016, May 19) retrieved 17 April 2021 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments